冒烟型骨髓瘤冒烟型骨髓瘤课程资讯【2026 EHA】特立妥单抗对比来那度胺+地塞米松方案提升HR-SMM缓解深度与PFS:Ⅱ期IMMUNOPRISM研究结果Htology血液前沿 | 2026-06-23